
Aplicación YC de Oncobox
Oncobox pasó por Y Combinator en el batch Summer 2017 como una empresa de Healthcare. Abajo: qué hace la empresa, quién la fundó y su aplicación a YC, reconstruida pregunta por pregunta en el formulario real de YC.
- Batch YC
- Summer 2017
- Industria
- HealthcareDiagnostics
- Tamaño del equipo
- 11
- Estado
- Active
- Lanzado
- 2017
Fundadores
Andrew GarazhaFounder/CEO
Anton BuzdinFounder/CSO
Lo que hace Oncobox
Oncobox believes that many late-stage cancer patients are dying prematurely because doctors lack a data-driven tool to help them decide which drugs currently on the market would most effectively fight individual patients’ specific cancers. That’s where Oncobox comes in. Oncobox is low-cost personalized genetic profiling to help doctors decide which drug to use. In a recent study conducted by leading cancer researchers in Europe and Asia on 900 patients with various late-stage cancers, Oncobox increased the effectiveness of targeted therapies from 25% to 64%. How does Oncobox work? Over 150 targeted cancer drugs are currently on the market. But deciding which of these drugs to give to late-stage cancer patients is not a simple task. Cancer doctors are in a race against the clock. They don’t always know which medication will be most effective for their patients. Because these drugs are expensive and typically have significant side effects, they can’t just try them all. Because of these barriers, targeted cancer therapies are effective only 25% of the time, and 70% of patients with late-stage cancers die due to the toxic side effects of ineffective drugs. Oncobox Dx analyses tumor DNA, RNA, and molecular pathways using algorithms to distinguish which molecular targets are the most crucial for individual cases. Doctors receive a clinically actionable report that shows them which drugs are likely to be most effective on the patient. We actively seek partners from pharma, hospitals/clinicians, payers, and genomic centers. Feel free to contact us at. Our team and the scientific advisory board consisting of leading scientists and researchers from UCLA, Stanford, Johns Hopkins University, Boston University, Tufts University, and Rutgers University.
Aplicación YC de Oncobox, reconstruida
Solicitud de Y Combinator
Oncobox, batch Summer 2017. Las preguntas reales del formulario, respondidas con datos públicos.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Oncobox
Finding the right cancer drug for each patient.
Oncobox analyzes tumor DNA, RNA, and molecular pathways to produce a report that helps oncologists pick the most effective targeted cancer drugs for an individual patient. Our product focuses on late-stage cancer patients, where current targeted therapies only work 25% of the time. Our system increases that effectiveness significantly by identifying the key molecular targets specific to each tumor.
We live in Walnut, CA and would base the company here after YC.
We are already based in Walnut, CA and want to stay here because of access to regional research partners and proximity to biotech clusters in California.
21 respuestas más en la aplicación completa
están en la versión completa. Crea una cuenta gratuita para abrirla en YC Insights, junto a cada otro batch de YC.
Preguntas Frecuentes
¿Es esta la aplicación YC real de Oncobox?
No. Y Combinator mantiene privadas las aplicaciones enviadas. Esta es una reconstrucción: las preguntas reales del formulario de YC, respondidas a partir de los datos públicos de Oncobox (notas de lanzamiento, antecedentes de fundadores, descripción del producto). Muestra cómo una empresa como Oncobox se presentaría a YC, no el texto que enviaron.
¿En qué batch de YC estuvo Oncobox?
Oncobox formó parte del batch Summer 2017 de Y Combinator.
¿Quién fundó Oncobox?
Oncobox fue fundado por Andrew Garazha, Anton Buzdin.
¿A qué se dedica Oncobox?
Finding the right cancer drug for each patient.
¿Cómo leo la aplicación completa reconstruida?
Crea una cuenta gratuita de Round Funded. La versión completa de 26 respuestas de la aplicación de Oncobox, y de cada otro batch de YC, está en YC Insights.